Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelets and anti-platelet therapy.

Archibald McNicol1, Sara J Israels

  • 1Department of Oral Biology, University of Manitoba, Winnipeg, Canada. mcnicol@ms.umanitoba.ca

Journal of Pharmacological Sciences
|January 23, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Atypical presentations of neonatal and infantile hemophilia B.

Frontiers in pediatrics·2026
Same author

Corrigendum: Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study.

Frontiers in oncology·2024
Same author

Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study.

Frontiers in oncology·2024
Same author

Mental Disorders Among Adolescents and Young Adults With Cancer: A Canadian Population-Based and Sibling Cohort Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Acquired haemophilia A: A 15-year population-based review of incidence rate, patient demographics and treatment outcomes.

Haemophilia : the official journal of the World Federation of Hemophilia·2023
Same author

Skin Lesions as a Presenting Feature of Dimorphic T-Lymphoblastic Leukemia in an Adolescent Male.

Journal of pediatric hematology/oncology·2023

Platelets are key in blood clotting and thrombosis. Current anti-platelet drugs target common pathways, but new research explores novel targets like the thrombin receptor for better treatments.

Area of Science:

  • Cardiovascular Biology
  • Hematology
  • Pharmacology

Background:

  • Platelets are crucial for hemostasis and thrombosis.
  • Activated platelets form thrombi, causing vessel occlusion and ischemic injury.
  • Existing anti-platelet therapies target cyclooxygenase and ADP receptors.

Purpose of the Study:

  • To review the role of platelets in thrombosis.
  • To discuss current anti-platelet drug mechanisms and limitations.
  • To explore novel therapeutic targets for anti-platelet therapy.

Main Methods:

  • Literature review of platelet physiology and anti-platelet drug mechanisms.
  • Analysis of clinical trial data for existing therapies.
  • Identification of emerging targets based on recent research.

Related Experiment Videos

Main Results:

  • Platelets aggregate, release agonists, and support thrombin generation.
  • Cyclooxygenase inhibitors and thienopyridines are established therapies.
  • Intravenous alpha IIb beta 3 antagonists show efficacy; oral forms are less successful.
  • Novel targets include thrombin, serotonin, and leptin receptors.

Conclusions:

  • Platelet function is central to thrombotic events.
  • Current anti-platelet strategies have limitations.
  • Emerging targets offer potential for improved anti-thrombotic therapies.